DDIS-26. HIGH-THROUGHPUT DRUG SCREENING OF MENINGIOMAS IDENTIFIES HDAC INHIBITORS AS PROMISING TARGETS ACROSS GRADES

Meningiomas are a common central nervous system (CNS) tumor, accounting for one third of CNS neoplasms. To date, no FDA approved pharmacotherapy exists for meningiomas. In an effort to identify potential treatments for meningiomas we created a culture system that allows us to grow and screen tumors...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Tatman, Philip, Fringuello, Anthony, Wroblewski, Teddy, Scherer, Sam, Foreman, William, Ryan Ormond, D, Damek, Denise, Lillehei, Kevin, Jensen, Randy, Graner, Michael
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2019
Pynciau:
Drug Discovery
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847367/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.277
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg